Revance Therapeutics, Inc. (RVNC)
Feb 6, 2025 = RVNC was delisted (reason: acquired by Crown Laboratories)
3.650
0.00 (0.00%)
Inactive · Last trade price on Feb 6, 2025
Chuy's Holdings Market Cap
Revance Therapeutics is not actively traded anymore. When Revance Therapeutics last traded, it had a market cap or net worth of $383.05 million.
Market Cap
383.05M
Enterprise Value
n/a
1-Year Change
-27.66%
Ranking
n/a
Category
Stock Price
$3.65
Market Cap Chart
Since February 6, 2014, Revance Therapeutics's market cap has decreased from $476.44M to $383.05M, a decrease of -19.60%. That is a compound annual growth rate of -1.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2025 | 383.05M | 20.11% |
| Dec 31, 2024 | 318.90M | -58.68% |
| Dec 29, 2023 | 771.88M | -49.18% |
| Dec 30, 2022 | 1.52B | 29.62% |
| Dec 31, 2021 | 1.17B | -37.87% |
| Dec 31, 2020 | 1.89B | 129.62% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition